Conjunctivitis

Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution

PR News Wire (Free subscription) | 11/06/2009

DETROIT, Nov. 6 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) has launched ketorolac tromethamine ophthalmic solution, 0.5% following a final approval from the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA) for generic Acular® ophthalmic solution on the first day following patent expiration. This strength of ketorolac...

Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution

PR News Wire (Free subscription) | 11/06/2009

DETROIT, Nov. 6 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) has launched ketorolac tromethamine ophthalmic solution, 0.5% following a final approval from the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA) for generic Acular® opthalmic solution on the first day following patent expiration. This strength of ketorolac...

The Health benefits of Ajeran

Herbal medicine (Free subscription) | 11/03/2009

Many of plant can use for medical purpose like Ajeran(Bidens Pilosa). Ajeran include in Asteraceae Familia.In Southeast Asia a decoction was drunk for coughs and the juice of leaves dropped into the eye for conjunctivitis. In Africa young shoots where chewed for the relief of rheumatism and strong decoction of the leaves was drunk for any inflammation A diffusion was used to treat dysentery –...

New mascara

Skarlet on the universe (Free subscription) | 10/30/2009

Admittedly I still had another 2 months to go on my 17 lasting fix, but tbh it's so boring and hardly does anything special to my lashes that I thought I'd treat myself and open the second dior one I got as my present from boots when I worked there. You might remember that I was a massive fan of the first one I tried, diorshow iconic (I never managed to get a proper pic of it, but 3 FOTDs using it...

Newly approved drugs(FDA September-October 2009)

Inquisitives (Free subscription) | 10/29/2009

Here are some newly approved drugs, vaccines and some new indications for old drugs. Ofatumumab CD20-directed cytolytic monoclonal antibody indicated for the treatment of patients with chronic lymphocytic leukemia. Pazopanib kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma Cervarix human papillomavirus bivalent (types 16 and 18) preventative cervical cancer...

Conjunctivitis Therapy Area Pipeline Report

aarkstore | 10/29/2009

Conjunctivitis Therapy Area Pipeline Report contains detailed information on the conjunctivitis drug pipeline. This report provides insight into the pipeline status of conjunctivitis drugs by company and by stage as well as a summary of the latest news and developments in this area. Scope of the report: Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and

ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data At The American College Of Clinical Pharmacy (ACCP) 2009 Annual Meeting

Medical News Today (Free subscription) | 10/22/2009

ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) announced poster presentations of results from the Company's Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies in allergic conjunctivitis. The studies demonstrated Bepreve was safe and well-tolerated when given twice daily for six weeks in a healthy pediatric population as young as three years of age.

• ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the American College of Clinical Pharmacy (ACCP) 2009 Annual Meeting - Red Orbit

ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the American College of Clinical Pharmacy (ACCP) 2009 Annual Meeting

PR News Wire (Free subscription) | 10/21/2009

ANAHEIM, Calif., Oct. 21 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced poster presentations of results from the Company's Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies in allergic conjunctivitis. The studies demonstrated Bepreve was safe and well-tolerated when given twice daily for six weeks in a healthy pediatric population...

Types of Pink Eye Information

Ask The Doctor: Medical Health (Free subscription) | 10/21/2009

"Pink Eye" is one of the most common ocular conditions patients suffer from. "Pink Eye" or more formally know as conjunctivitis comes in three major forms- bacterial, viral and allergic. Determining which specific type of conjunctivitis a patient has is essential to the proper management and treatment of the condition. Bacterial conjunctivitis is an infectious condition usually...

Case Report: Occupational Inhalant Allergy to Pork followed by Food Allergy to Pork and Chicken

Allergy Notes (Free subscription) | 10/16/2009

Typically, animal-derived proteins are implicated in food allergies. However, animal proteins can play a role in inhalant allergies with secondary food allergy symptoms. A 42-year-old female with a history of occupational inhalant allergy to pork reported rhinitis, asthma, dysphonia and conjunctivitis 30 minutes after ingestion of chicken. Skin tests were positive to chicken meat. Protein extracts...

Some Good Can Come From Swine Flu

Freakonomics (Free subscription) | 10/12/2009

A very common ailment in Korean summers and falls is pinkeye (conjunctivitis), and the problem had been getting much worse in the past two years. My Korean co-author tells me, however, that the H1N1 virus has created a positive externality in Korea.

Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease

PR News Wire (Free subscription) | 10/02/2009

CRANBURY, N.J., Oct. 2 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) today announced preliminary results from its Phase 2 randomized, open-label study to assess the safety, tolerability and preliminary efficacy of its investigational drug, Plicera(TM) (afegostat tartrate), in treatment-naive adult patients with type 1 Gaucher disease. Two dose regimens of Plicera (225 mg three days on/four...

Pink Eye Treatment And Symptoms

JeyamArticle (Free subscription) | 09/30/2009

Pink eye, also called conjunctivitis, is an inflammation of the conjunctiva which is the membrane that lines the eyelid and eye surface. The inflammation of pink eye can cause eye redness, swelling of the eyelids, tearing, itching, burning, sensitivity to light, drainage from the eye, and feeling as if there is something in the eye.

Possible Side Effects with Latisse

The Latest Beauty News Blog (Free subscription) | 09/29/2009

Possible side effects. The most common side effects after using LATISSE® solution are an itching sensation in the eyes and/or eye redness. This was reported in approximately 4% of patients. LATISSE® solution may cause other less common side effects which typically occur on the skin close to where LATISSE® is applied, or in the eyes. These include skin darkening, eye irritation, dryness...

Conjunctivitis Therapy Area Pipeline Report

aarkstore | 09/24/2009

Conjunctivitis Therapy Area Pipeline Report contains detailed information on the conjunctivitis drug pipeline. This report provides insight into the pipeline status of conjunctivitis drugs by company and by stage as well as a summary of the latest news and developments in this area. Scope of the report: Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and

Conjunctivitis Therapy Area Pipeline Report

aarkstore | 10/29/2009

Conjunctivitis Therapy Area Pipeline Report contains detailed information on the conjunctivitis drug pipeline. This report provides insight into the pipeline status of conjunctivitis drugs by company and by stage as well as a summary of the latest news and developments in this area. Scope of the report: Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and...

Conjunctivitis Therapy Area Pipeline Report

aarkstore | 09/24/2009

Conjunctivitis Therapy Area Pipeline Report contains detailed information on the conjunctivitis drug pipeline. This report provides insight into the pipeline status of conjunctivitis drugs by company and by stage as well as a summary of the latest news and developments in this area. Scope of the report: Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and...